Provider Alert! NasonexTexas Children's Health Plan
Effective July 27, 2017, Nasonex will be reclassified from preferred to non-preferred. Fluticasone nasal will be the only preferred intranasal corticosteroid for allergic rhinitis. Patients requiring Nasonex on or after July 27, 2017 will require a prior authorization.
Prior authorization forms can be found here:
Questions? Please contact Navitus at 1-877-908-6023.